Clinical Trials at Stanford University
As of July 2026, 119 paid clinical trials are recruiting at Stanford University, located at 875 BLAKE WILBUR DRIVE, STANFORD, CA 94305-5847, phone (650) 723-6171 in Stanford, California. Active studies at this site cover conditions such as Autism Spectrum Disorder, Autism and Heart Failure. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Newly added in Stanford
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
Overvaluation of Weight and Shape Intervention vs The Body Project
A Pilot Study Using Gut-Directed Hypnotherapy for Hospitalized Patients
Alpha-synuclein Education and Disclosure in Individuals With Preclinical and Symptomatic Lewy Body Disease
TLI- and ATG-Enabled Minimization Protocol in Liver Transplantation
Clinical Trial Evaluating the Effects of Ganaxolone in Children With Autism
125 clinical trials at Stanford University
·Clear filters·↓ Download CSVA Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
Efficacy and Safety of Extended TARPEYO® Treatment Beyond 9 Months in Adult Patients With Primary IgA Nephropathy
Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer.
Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Pancreatic Ductal Adenocarcinoma (PDAC)
A Study of Pirtobrutinib in Participants With Immune Thrombocytopenia
A Study of EP0031 (Lunbotinib) in Patients With Advanced RET-altered Malignancies
A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropathy (PMN)
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
DALY II USA/ MB-CART2019.1 for DLBCL
A Study to Assess the Safety and Effectiveness of the UrOActive® Artificial Urinary sPHincter (AUS)
XVIVO Heart Box (XHB) With Supplemented XVIVO Heart Solution (SXHS) Continued Access Protocol (CAP)
Study Evaluating the Efficacy of KITE-753 Versus Axicabtagene Ciloleucel in Participants With Relapsed or Refractory Large B-Cell Lymphoma After First-Line Therapy
A Study of TORL-5-700 in Relapsed/Refractory Non Hodgkin's Lymphoma
AI-driven Total Parenteral Nutrition Platform
Safety, Tolerability, Pharmacodynamic, Efficacy, and Pharmacokinetic Study of DYNE-101 in Participants With Myotonic Dystrophy Type 1
A Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML)
Intratumoral Delivery of Viral Replicon (saRNA) Particles Expressing IL-12 in Head and Neck Cancer
BAFFR-targeting CAR T Cells for Patients With Relapsed or Refractory B-NHL
Post-Exablate Pregnancy Outcomes Registry Study: Exablate Treatment of Symptomatic Uterine Fibroids
Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU
Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy Volunteers
Surgical Evaluation for Upper Extremity Lymphedema (BioBridge)
Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies
Body Clocks - Coordination of Peripheral and Central Oscillators
Preoperative Hemodialysis Timing in Patients With End-Stage Kidney Disease: The POD-ESKD Pilot Trial
Early Introduction and Sustained Ingestion (EISI) Using Two Educational Opportunities in Infants
A First-in-Patient Study to Evaluate the Safety and Tolerability of HB-2121 as a Diagnostic for Celiac Disease
Phase II: Engagement and Clinical Impact of the Teleo Virtual Therapy Platform in Clinical Settings
Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
Optimizing Brain Excitability in Depression
The Society for Obstetric Anesthesia and Perinatology Research Network General Anesthesia Registry
Clinical and Genetic Evaluation of Individuals With Undiagnosed Disorders Through the Undiagnosed Diseases Network
SARC046: A Phase II Trial of Nab-Sirolimus in Patients With Progressing or Symptomatic Epithelioid Hemangioendothelioma
Oxytocin Pharmacokinetics and Pharmacodynamics
Using Continuous Glucose Monitoring to Quantify the Effects of NOURISH's Culturally Modified Meals on Asian Americans With Type 2 Diabetes
Sleep TMS for Depression
Evaluation of Dipyridamole in Preventing Post-Transplant Hypophosphatemia in Kidney Transplant Recipients
Type 1 Diabetes Extension Study
About research studies in Stanford
Stanford has approximately 418 recruiting research studies across a wide range of therapeutic areas. California hosts a dense network of world-class research institutions, including UC San Diego Health, Stanford Medicine, UCLA Health, UCSF, City of Hope, and Scripps Research. The state's thriving biotech corridor and diverse patient population make it a national hub for both early-phase and late-phase clinical research.
Common conditions studied in Stanford
- Autism Spectrum Disorder (17 active studies). Recruiting Autism Spectrum Disorder studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Autism (13 active studies). Recruiting Autism studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Cancer (7 active studies). Recruiting Cancer studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Heart Failure (7 active studies). Heart failure trials explore SGLT-2 inhibitors, novel myosin modulators, and device-based therapies for both reduced and preserved ejection fraction.
- Atrial Fibrillation (6 active studies). Atrial fibrillation studies investigate next-generation anticoagulants, ablation technologies, and left atrial appendage closure devices.
- Breast Cancer (6 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
Leading research sponsors in Stanford
- Stanford University
- Eli Lilly and Company
- AstraZeneca
- Memorial Sloan Kettering Cancer Center
- Novartis Pharmaceuticals
Local regulations and guidelines
Clinical trials in California are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. In addition, California-specific protections such as the California Consumer Privacy Act (CCPA) and the Confidentiality of Medical Information Act (CMIA) impose stringent data-privacy requirements on research involving California residents.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Stanford. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Stanford
Hipa.ai aggregates every recruiting study in Stanford from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Stanford?
There are approximately 418 recruiting clinical trials in Stanford, California listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Stanford pay participants?
Most recruiting trials in Stanford compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Stanford?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Stanford?
The most common conditions under active study in Stanford include Autism Spectrum Disorder (17), Autism (13), Cancer (7), Heart Failure (7), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Stanford?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Stanford on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Stanford?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Stanford?
Recruiting research sites in Stanford include Stanford University, Stanford University School of Medicine, Stanford University Medical Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Stanford right now?
The largest active categories in Stanford are Cancer & tumors (87), Cardiovascular (40), Neurology & pain (34). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of Stanford University?
Stanford University is located at 875 BLAKE WILBUR DRIVE, STANFORD, CA 94305-5847. Use the Google Maps link in the intro above to get directions.
How do I contact Stanford University?
You can reach Stanford University by phone at (650) 723-6171. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.